HLA-C (Cw6, Cw7)-specific genes were isolated either as genomic cosmid or cDNA clones to study the diversity of HLA antigens. The allele specificities were identified by sequence analysis in comparison with published HLA-B and -C sequences, by transfection experiments, and Southern and northern blot analysis using oligonucleotide probes. Comparison of the classical HLA-A, -B, and -C sequences reveals that allele-specific substitutions seem to be rare events. HLA-B51 codes only for one allelespecific residue: arginine at position 81 located on the cd helix, pointing toward the antigen binding site. HLA-B8 contains an acidic substitution in amino acid position 9 on the first central/3 sheet which might affect antigen binding capacity, perhaps in combination with the rare replacement at position 67 (F) on the c~l helix. HLA-B8 shows greatest homology to HLA-Bw42, -Bw41, -B7, and -Bw60 antigens, all of which lack the conserved restriction sites Pst I at position 180 and Sac I at position 131. Both sites associated with amino acid replacements seem to be genetic markers of an evolutionary split of the HLA-B alleles, which is also observed in the leader sequences. HLA-Cw7 shows 98% sequence identity to the JY328 gene. In general, the HLA-C alleles display lower levels of variability in the highly polymorphic regions of the c~ 1 and c~2 domains, and have more distinct patterns of locusspecific residues in the transmembrane and cytoplasmic domains. Thus we propose a more recent origin for the HLA-C locus.
Introduction
a polymorphic heavy chain (M r 40 000-45 000), encoded within the major histocompatibility complex (MHC) on the short arm of chromosome 6, and an invariant light chain (M r 12 000), beta-2 microglobulin (B2m), encoded on chromosome 15 (Goodfellow et al. 1975 , Grey et al. 1973 , Coligan et al. 1981 . Each heavy chain is composed of three extracellular domains (c~1, ~2, ~3) of about 90 amino acids, a hydrophobic transmembrane segment, and a hydrophilic cytoplasmic region. The products encoded by three gene loci (HLA-A, -B, and -C) serve as restriction elements for virus-specific and allospecific cytotoxic T lymphocytes (CTL) and are therefore major determinants in directing tissue graft rejection (Zinkernagel and Doherty 1979) . Additional non-H/A-A, -B, and-C genes of unknown function map between the HLA-B and/or around the HLA-A locus . A characteristic feature of the classical class I products is their very high degree ofpolymorphism, mainly in the c~l and ~2 domain, which occurs within a highly organized framework of conserved sequences. The c~3 domain and B2m are relatively conserved and show amino acid sequence homology to immunoglobulin constant domains (Orr et al. 1979 , Peterson et al. 1972 , Trfigardh et al. 1979 , Smithies and Poulik 1972 . The transmembrane and cytoplasmic regions contain the majority of locus-specific residues and reveal a higher degree of intralocus conservation which reflects evolutionary ancestry rather than positive selection (Gfissow et al. 1987) .
We have isolated additional HLA class I genes and present here the molecular structures of to the HLA genes published to date.
HLA (human leucocyte antigen) molecules are membrane glycoproteins found on the surface of nearly all nucleated cells which are formed by a noncovalent association of
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Materials and methods
Isolation of the HLA-B and HLA-C clones.
The HLA-B-specific cd2.6 (HLA-B27) cosmid (Weiss et al. 1985) and the allelic cd3.3 cosmid were isolated from a genomic library (cd) constructed from peripheral white blood cells of a healthy donor (HLA-type: A2, B27/B51, Cw2/Cw3).
Two other HLA-B-specific clones pMF18 and pMF28, and the HLA-C-specific clone pMF17 were isolated from a cDNA library (MF) kindly provided by A. Hahn, prepared from RNA of a chronic T-cell leukemia (HLA-type: A 1/A2, B8/Bw62, Cw3/Cw7). The HLA-C-specific clones pMS 1 and pMS24 were identified in a second cDNA library (MS) constructed fiom RNA of thymocytes (HLA-type: A2/A30, BI3, Cw6). The libraries were screened by differential hybridization using a fulllength class I probe derived from a B27 cDNA clone, an HLA-B-specific probe derived from the 3' untranslated region, and a 200 bp Pvu II x Sac I HLA-C-specific fragment spanning the region of amino acids 246-312, part of the c~3 domain, and the transmembrane segment of the HLA-Cw 1 cDNA (Sz6ts et al. 1986 ). The probes were labeled by the random primer method (Feinberg and Vogelstein 1983) with c~-32p-dATP (3000 Ci/mmol).
DNA sequencing. The DNA sequence analysis of M13 subclones was carried out by the dideoxy chain termination method (Sanger et al. 1977 ).
Southern and northern blot analysis• Southern blot analysis of genomic DNA from various HLA haplotypes was done according to standard protocols (Southern 1975) . A 1350 bp Sac I fragment from the 5' end of the HLA-B27 gene (Weiss et al. 1985) was selected for hybridization• Slot blot analysis with isolated RNA was performed with the Minifold II SRC 072/0 as described by the supplier (Schleicher and Schuell, Dassel, FRG) . Purification of the oligonucleotides (synthesized by Dr. R. Mertz, Genzentrum, Munich, FRG) and hybridization was done as described (Geliebter et al. 1986 ) with the modification that the probe was labeled with terminal desoxynucleotidyl transferase and e~-32p-dATP (Collins and Hunsaker 1985) .
HLA haplorvpe of the cells used for the studies.
EBV-transformed B-cell lines. AS (A1, B8, Cw7); CoL (A2/A3, B18/B51, Cw5); DS (A2/A3, B35/B37, Cw4); FrDa (A?, B27/?, C?); Juso (AI/A2, B7/B8, C?); KR (A2, B44, Cw5); LG2 (A2, B27, Cwl); LiCa (A3, B7, Cw7/Cw8); ML (A2/A3, B7/B27, Cw2); MWi (A2, B18/B35, Cw4/Cw7); Ni (A3/A29, B35/Bw65, Cw4/Cw8); RL (A2/A23, B13/B27, Cw3/Cw6); Sweig (A29, B40*, C?); TY (All, B35, Cw4); VL (A2/A3, B13/B18, Cw5/Cw6); WDV (A3, B38, C!).
The T-cell leukemia line MF. (A1/A2, B8/Bw62, Cw3/Cw7).
The peripheral blood lymphocytes. CD (A2, B27/B51, Cw2/Cw3); CW (A24/A28, B44/Bw60, Cw3/Cw5); DB (A2, B44/Bw41, C?); Eb (A3/A32, B7/B51, Cwl); EW (A2/A30, B13/Bw62, Cw3/Cw6); GS (A2, B49/Bw62, Cw4); JZ (A25/A30, B18/Bw41); KL (A2/A3, B7/B35, Cw4); MS (A2/A30, B13, Cw6); PH (A2/A26, Bw62/?, Cw3); and in addition K562, a human chronic myelogenous leukemia cell line (HLA class I negative) and SW480, a human colorectal adenocarcinoma cell line (A2, B8/B17, C?).
Results
Characterization of HLA-B-and -C-specific sequences.
HLA-B51 is contained in the cosmid cd3.3 isolated from the genomic library (cd). The restriction map of the cd 3.3 clone and the sequencing strategy are shown in HLA-B8 is encoded by the pMF28 clone, which hybridized with the HLA-B locus-specific probe. Figure  1 shows the restriction map of pMF28 and the sequencing strategy. Neither this clone nor the other cDNA clones possess the entire leader peptide and thus could not be used directly for transfection experiments to determine the HLA specificity. Partial sequence information of exons 5, 6, and 7 of the HLA-B-specific cDNA clone pHLA-1, isolated from the homozygous cell line LKT (HLA-A1/-B8; Ploegh et al. 1980) , indicated that pMF28 encodes HLA-B8. The protein sequence ofpMF28 is also identical in the three extracellular domains to that of the published B8 antigen cloned from the heterozygous lymphoblastoid cell line (LCL) 721 .
HLA-Bw62, the second allele of the heterozygous individual MF, must be encoded by the second clone, pMF18, identified with the HLA-B-specific probe. pMF 18 reveals a restriction pattern distinct from the pMF 28 clone, as shown in Figure 1 . To assign the pMF18 clone to HLA-Bw62, a specific oligonucleotide derived from the region of amino acids 42-48 in the o~1 domain was synthesized; this sequence was subsequently found to be present in the HLA-B13 sequence (Zemmour et al. 1988) . The Bw62/B13 oligomer was used to correlate the expression of the HLA-Bw62 antigen with the presence ofmRNA shown by the slot blot analysis (Fig. 2) . Specific bands were found only in those cells having Bw62 and/or B13.
Assignment of the HLA-Cw6 and Cw7 alleles. DNA sequence determination of the clone pMF17, pMS1, and pMS24, hybridizing with the HLA-C-specific probe, confirmed the typical transmembrane and cytoplasmic regions found only in HLA-C sequences (see Figs. 3 and 4) . Furthermore, they showed the HLA-C-specific amino acid pattern in the cd domain (amino acid 45, 66-76). pMF 17 differs from the published Cw3 sequence and thus should encode the HLA-Cw7 antigen, the second HLA-C allele of individual MF. The clones pMS 1 and pMS24 are identical and very likely encode HLA-Cw6, since individual MS carries HLA-B13 and -Cw6 on both chromosomes. The parents of MS were HLA typed to confirm that MS inherited HLA-B13 and -Cw6 from both parents.
HLA class I sequence analysis. The amino acid sequences deduced from these HLA class I clones are compared with other published HLA antigen sequences (Fig. 4) . The sequences of the known nonclassical class I loci JY328 (Srivastava et al. 1985) , pHLA6.0 , HLA-E (LG2-C1), and the pseudogene pHLA12.4 (Malissen et al. 1982) are also included. In addition, the defective class I sequence, pLN-11A (Biro et al. 1983) , was evaluated when locus-specific residues were assigned, although this sequence is not included in Figure 4 .
LG2-C1 is a full-length cDNA clone isolated from the LG2 cDNA library (Sz6ts et al. 1986, Pohla and corresponding to the RS5 sequence (Srivastava et al. 1987) and is identical to HLA-E and JTW15 (Mizuno et al. 1988 ) except for one substitution in amino acid position 222 (R=AGG instead of E=GAG). This sequence comparison reveals that HLA-B51 contains one allele-specific amino acid: arginine, a basic residue at position 81 replaces the common nonpolar amino acids alanine or leucine of other genes, pointing toward the antigen binding site, according to the X-ray crystal!ographic structure analysis of the HLA-A2 molecule (Bjorkman et al. 1987a, b) . The histidine present at position 171 instead of the highly conserved tyrosine is also found in HIA-B14 (-Bw65) and -B18 ). This histidine could also affect interactions between the MHC molecule and distinct processed antigens, for instance with the backbone of a peptide. As a member of the Bw4 subgroup, HLA-B51 shows the sequence 80(T), 82(L), and 83(R), postulated to be specific for the Bw4 epitope (Wan et al. 1986 ). The monoclonal antibody $4, which recognizes the HLA-B51 antigen, also reacts with additional HLA-B alleles (Bw52, B13, B44, B45, Bw57) . Analysis of these sequences discloses one epitope shared by the HLA-B alleles: asparagine at position 77 together with the Bw4 characteristic residues 80, 82, and 83, which may account for the antibody specificity.
The highest overall sequence identity of HLA-B8 was found with HLA-Bw42 and -Bw41 (Parharn et al. 1988) and HLA-B7, -B40*, and -Bw60. With the exception of the HLA-B40* mutant, all these antigens share identical substitutions at amino acids 131 (R) and 180 (E), which hybridizing band of 3.1 kb is also present in the WDV DNA. Since a 1.35 kb Sac I fragment gives a strong hybridization signal, this most likely represents B38, while the former fragment must be derived from another class I sequence in the WDV genome. In the case of Pst I x Eco RI double-digested DNA (data not shown), the 1.35 kb Sac I probe detects a strongly hybridizing 1.9 kb Pst I fragment specific for the HLA-B7, -B8, -Bw41, and -Bw60 haplotypes lacking the Pst I site at the end of exon 3 instead of a 1.65 kb Pst I fragment, which is present if glutamine replaces glutamic acid at position 180. HLA-B8 contains an aspartic acid on the first/3 strand of the cel domain at position 9, which has been defined as a potential ligand for an antigenic peptide. Interestingly, this rare acidic substitution is located on the same side of the groove as the highly polymorphic residue 67 (HLA-B8: F) and might join in antigen binding. At the nucleotide level, position 9 is associated with an additional Taq I restriction site (see Figs. 1 and 3 ). HLA-Bw62 is characterized by a high degree of similarity in the first domain with the HLA-B 13 sequence. The major differences lie in the cluster of amino acids 77-83 encompassing the Bw6 epitope. HLA-Bw62, in the first half of the al domain, is identical to the sequence of the HLA-B51 and the HLA-Bw58 molecules. In this case, the antigens share serological crossreactivity. The sequence comparison also shows that the HLA-Bw62 antigen has sequence identity with HLA-B40*, -Bw60, -Bw41, -B13, -B44, and -Bw47 between amino acids 62 and 76. Zemmour and co-workers (1988) proposed this linear sequence to be responsible for the serological crossreactivity between HLA-B13 and -Bw47 and as a possible epitope for the crossreactivity observed with molecules of the HLA-B12-and HLA-B40*-related groups. Since the same sequence is also preserved in the HLA-Bw62 antigen which does not display any crossreactivity with the above-mentioned specificities, this region alone cannot explain the serological patterns.
The Cw7 sequence contains one allele-specific residue at position 273 (S) and is virtually identical (98%) to the JY328 sequence (Srivastava et al. 1985) , but differs from the other HLA-C alleles (90-93 %) as a result of several unique substitutions in the conserved cd domain, transmembrane and cytoplasmic regions (amino acids 194,261,267,305,307,326,339; shown in Fig. 4) . The high sequence similarity explains the Cw7 reactivity of the JY328 transfectants (Duceman et al. 1986 ).
Discussion
To study the diversity of HLA antigens, several new HLA-B-and HLA-C-specific genes were isolated and compared with previously published sequences. When non-HLA-A/-B/-C class I sequences are included in such a comparison, only a few locus-specific residues can be Weiss et al. 1985) was used as the hybridization probe. The genomic DNA of lane Ni shows slight degradation identified. These include not only the HLA-A-specific residues, amino acids 71 (S) and 299 (I), and the HLA-Bspecific residues, amino acids 239 (R) and 300 (I), but also several HLA-C locus-specific residues: 45 (G), 297 (L), 298 (A), 300 (L), 321 (C), 335 (E), and 338 (I), and in addition the eighth exon encoding an alanine residue.
This sequence comparison also confirms that allelespecific substitutions are rare events and probably the result of point mutations. Half of the amino acid replacements are localized within a framework of conserved sequences and not in the polymorphic regions. Thus, individual alleles are characterized by a cluster of amino acid substitutions, and a unique constellation of polymorphic residues affects the recognition of antibodies and the T-cell receptor.
As was pointed out previously for the HLA-A and HLA-B molecules, polymorphic amino acids display locus-specific distributions . Figure  6 analyzes the variability of HLA-C molecules, as revealed for eight known HLA-C sequences, including Cw2.2 ), JY328 (Srivastava et al. 1985) , and Cx52 (Takata et al. 1988) . Although the number of sequences is still limited, this analysis reveals that only two positions (amino acids 9, 116) for HLA-C exhibit more than three different amino acids. Thus, the HLA-C alleles are characterized by a somewhat lower level of variability in the regions of the o~1 and o~2 domain which are highly polymorphic in HLA-A and -B. The highly polymorphic region at the end of the cd domain in HLA-A and -B is rather invariant in the HLA-C alleles. Together with the more distinct pattern of locus-specific residues in the transmembrane and cytoplasmic domains, one could propose a more recent origin for the HLA-C locus. The variability seen in o~3 is higher for the HLA-C locus than for the HLA-A and HLA-B molecules. This is accounted for mainly by the HLA-Cw7 and JY328 sequences which differ at five positions from the other HLA-C alleles.
In an attempt to find restriction sites and sequence similarities which might reflect evolutionary relationships among the HLA-B alleles, we used several single-copy probes derived from the HLA-B locus to investigate a large number of haplotypes (Weiss et al. 1988) . Using gene flanking probes, polymorphisms in the gene flanking regions which correspond with sequence similarities in the coding regions were generally not found. However, some patterns might be interpreted in this direction. For HLA-Bw62, -B51, and -Bw58 we found identity in the transmembrane and cytoplasmic regions even at the nucleotide level; only one nucleotide substitution was found in the first half of exon 2, and minor differences are present in the 3' untranslated region.
Interestingly, two restriction sites were found, which are present in more conserved positions when all class I sequences were compared, and which divide the HLA-B genes into two groups. The larger group of alleles contains the restriction sites Sac I and Pst I as genetic markers for serine at position 131 and glutamine at position 180. The alleles HLA-BZ -B8, Bw41, -Bw42, and -Bw60 are members of the second group. They lack these restriction sites and encode an additional identical residue (D) at position 177. One exception is the HLA-B40* antigen which was postulated to have lost the epitope encompassing amino acids 177 and 180 by gene conversion, a result which supports this evolutionary relationship of HLA-B alleles. The relationship is also observed when comparing the leader sequences of the HLA-B7 and -B8 genes (only Parham et al. 1988 ), JY328 (Srivastava et al. 1985) , and Cx52 (Takata et al. 1988 ). Cw2.2 only differs from Cw2.1 at position 49/50 (A/P in place of G/R). The protein 26o sequences were analyzed as described by Wu and Kabat (1970) .
Number of different amino acids at a given position Variability = Frequency of the most common amino acid at that position protein sequences of the mature antigens have been published for the other alleles of this group, see Fig. 4) . Similarly, the leader peptides of the HLA-A and HLA-C molecules share a characteristic amino acid pattern. Surprisingly, the two recently published HLA-B homologous sequences from chimpanzee also contain the same set of amino acid substitutions as the uncommon serine at position 131, glutamic acid at 177, and glutamine at 180, present in the one group of HLA-B alleles , Mayer et al. 1988 ). This pattern of similarity leads to the conclusion that this divergence in an ancestral -B sequence arose before separation of the human and chimpanzee species (Klein 1987 , Mayer et al. 1988 ).
